Skip to main content
en-GBii-CN

Strategic Review (ii-CN)

We regret that, due to regulatory restrictions, we are unable to provide you with access to this section of our website. Please click here to return to the homepage

On 18th April 2023 Advanced Oncotherapy plc announced the commencement of a strategic review

This page contains documents related to the strategic review: